RSSDI Repository, Complications of Diabetes Demonstration
RSSDI Repository, Complications of Diabetes Demonstration

Have a Question?

If you have any question you can ask below or enter what you are looking for!

Advanced Search
  • Home/
  • Article /
  • Efficacy of rituximab versus tacrolimus in difficult-to-treat steroid-sensitive nephrotic syndrome: an open-label pilot randomized controlled trial

Efficacy of rituximab versus tacrolimus in difficult-to-treat steroid-sensitive nephrotic syndrome: an open-label pilot randomized controlled trial

Add to Collection
RCTs G Mathew, A Sinha, A Ahmed, N Grewal… - Pediatric …, 2022 - Springer

Chapter : Section22, Section24, Section2
Journal Year : 2022
Cited by : 9

… two strategies [4, 31, 32]. This definition was also endorsed in the revised guidelines of the Indian … and were enrolled early in disease course (median duration of disease 2.5 years). …..... Read More

Keywords : ['openlabel pilot randomize control trial', 'difficulttotreat steroidsensitive nephrotic syndrome', 'rituximab versus tacrolimus', 'efficacy']
PubMed Link : https://link.springer.com/article/10.1007/s00467-022-05475-8
Google Scholar Link : https://scholar.google.com/scholar?cites=8967715264049057023&as_sdt=80000005&sciodt=0,23&hl=en&num=20